ClinicalTrials.Veeva

Menu

Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs (MetaCOGNITION)

C

Centre Hospitalier Charles Perrens, Bordeaux

Status

Completed

Conditions

Schizophrenia
Bipolar Disorder

Treatments

Other: QUESTIONNAIRES

Study type

Interventional

Funder types

Other

Identifiers

NCT04590300
2020-A00980-39

Details and patient eligibility

About

People with schizophrenia and bipolar disorder display alterations in cognition and metacognition. These alterations may have an impact on learning during therapeutic education programs.

Full description

Patient Therapeutic Education (FTE) is defined as a practice to help patients to acquire or maintain the skills needed to best manage their lives with a chronic disease. FTE includes organized awareness, information, learning and psychological and social assistance about the disease, prescribed treatments, various treatments offered, as well as information on organization of the global health system, and health behaviours. Performed by health professionals trained in this practice, FTE is intended to help patients and their close relatives and to understand their pathology, their treatments, collaborate with health care teams, and maintain or improve their quality of life. It aims to produce a complementary therapeutic effect of other health care interventions

Enrollment

108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consent to participate in the study,
  • Suffering from a chronic condition for which an therapeutic patient education (TEP) program is proposed.
  • Mastering the French language.
  • Be a beneficiary of health insurance

Exclusion criteria

  • Poor understanding of instructions that make it impossible to consent or assess
  • Neurodegenerative disease

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

108 participants in 2 patient groups

Schizophrenia
Other group
Description:
1 questionnaire at the beginning of the study, before FTE program 1 questionnaire at the end of FTE
Treatment:
Other: QUESTIONNAIRES
Bipolar disorder
Other group
Description:
1 questionnaire at the beginning of the study, before FTE program 1 questionnaire at the end of FTE
Treatment:
Other: QUESTIONNAIRES

Trial contacts and locations

1

Loading...

Central trial contact

Helen SAVARIEAU; Clelia QUILES, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems